ProCE Banner Series

Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?

Alpha-1 antitrypsin deficiency associated liver disease (AATD-LD) is a leading genetic cause of liver disease, yet it remains largely underdiagnosed and poorly understood. This encore webinar from a live symposium will feature a multispecialty panel of experts who will provide insights into the pathophysiologic and genetic underpinnings of AATD-LD, best practices in diagnosis, guidance for navigating management, and emerging therapies with the potential to improve patient outcomes.

  AMA
  | EBAC®
  | EBAC®
Who Should Attend

This program is intended for a primary target audience of hepatologists, gastroenterologists, and pulmonologists, as well as a secondary audience of primary care providers, nurse practitioners, physician associates, and pediatricians who manage patients with AATD.

All Events

Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?

Upcoming Events

January

14

2025

6:00 PM - 7:00 PM Eastern Time (ET)

Virtual

Past Events

November

17

2024

12:30 PM - 2:00 PM Pacific Time (PT)

In-person

San Diego Convention Center, 111 W Harbor Drive, San Diego, California 92101

1:00 PM - 2:00 PM Pacific Time (PT)

Virtual

Faculty

ProCE Banner Faculty
Mark Brantly, MD

Professor Emeritus
Department of Medicine
University of Florida College of Medicine
Gainesville, Florida

ProCE Banner Faculty
Virginia Clark, MD, MS

Clinical Professor of Medicine
Division of Gastroenterology, Hepatology, & Nutrition
University of Florida College of Medicine
Gainesville, Florida

ProCE Banner Faculty
Pavel Strnad, MD

Full Professor
Department of Internal Medicine III
University Hospital Aachen
Aachen, Germany

ProCE Banner Faculty
Jeffrey Teckman, MD

Drs Patrician and James Endowed Chair
Professor of Pediatrics and Biochemistry and Molecular Biology
Vice Chair of Pediatrics
St Louis University School of Medicine
Cardinal Glennon Children’s Hospital
St Louis, Missouri

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of HCPs in diagnosing and assessing AATD-LD and provide them with practical strategies for optimizing disease management.

Target Audience
This program is intended for a primary target audience of hepatologists, gastroenterologists, and pulmonologists, as well as a secondary audience of primary care providers, nurse practitioners, physician associates, and pediatricians who manage patients with AATD.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify clinical manifestations of AATD-LD

  • Position recommended diagnostic procedures for suspected AATD-LD

  • Implement noninvasive tests to assess liver fibrosis in patients with AATD-LD 

  • Summarize investigational therapeutic approaches for AATD-LD 

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

EBAC® Accreditation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/670013d9e7266.jfif

This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for up to 1.0 hour of external CE credit. Each participant should claim only those hours of credit that have actually been spent in the educational activity.

The Accreditation Council for Continuing Medical Education (ACCME®), and the Royal College of Physicians and Surgeons of Canada hold an agreement on substantial equivalency of accreditation systems with EBAC®.

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC® CE credits/points to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Total effective education time: 1 hour

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Takeda Development Center Americas, Inc.